Processa Pharmaceuticals director Sheila Gujrathi files initial beneficial ownership statement
PCSA•Form 3 filing by director
- Processa Pharmaceuticals director Sheila Gujrathi filed an initial Form 3 beneficial ownership statement dated July 28, 2026.
